CMS issues billing code for Lymphoseek
Article Thumbnail ImageAugust 21, 2013 -- The U.S. Centers for Medicare and Medicaid Services (CMS) has issued a billing code for the Lymphoseek radiopharmaceutical from Navidea Biopharmaceuticals.

To get access to this article and all of the content on AuntMinnie.com, create a free account or sign-in now.

Member Sign In:
  MemberID or E-mail Address:
  Password:
(?)

New AuntMinnie.com Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • Online CME
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
  • CMS issued a pass-through C-code under the Healthcare Common Procedure Coding System (HCPCS), which Navidea believes will streamline billing and reimbursement for healthcare providers using the product, a technetium-99m agent for lymphatic mapping. Navidea believes the billing code will become effective on October 1.

    Lymphoseek was approved by the U.S. Food and Drug Administration (FDA) in March to assist in the localization of lymph nodes draining a primary tumor in patients with breast cancer or melanoma.


    || About || Advertising || AuntMinnieCME.com || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2014 || Education || Equipment Classifieds || Europe || Facebook || Forums || Home || Links || Marketplace || Middle East || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2013 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2014 AuntMinnie.com. All Rights Reserved.